Delivery Order SPE2DB20D3103-SPE2DB25FN5V9
Award Date 4/24/25
Potential Completion Date 4/25/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,073.56 to AmerisourceBergen Drug Corp for VIMPAT 150 mg tablets (60 unit dose tablets) on October 21, 2025, with a completion date of October 22, 2025. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VIMPAT 200 mg tablets (60-count) on October 27, 2025, with a ceiling value of $2,117.02. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 28, 2025. The award represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of VIMPAT 100 mg at a ceiling value of $1,089.84 under a firm fixed price contract type. This award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of VIMPAT 200 MG tablets in a quantity of 60 units, with a contract ceiling value of $1,089.82. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The contract has an ultimate completion date of July 28, 2025, and AmerisourceBergen will perform this work from its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,874.60 to AmerisourceBergen Drug Corp for VIMPAT 10 mg/mL solution in a 200 mL quantity. This contract, which was competitively awarded without a set-aside designation, represents a firm fixed price delivery order with an ultimate completion date of August 27, 2025. VIMPAT (lacosamide) is an antiepileptic medication used to treat partial-onset seizures, reflecting the critical pharmaceutical supply needs of federal military and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for VIMPAT 10 mg/mL solution in 200 mL quantities, valued at $1,322.67, with a completion date of September 9, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of VIMPAT 10 mg/mL solution in 200 mL quantities, valued at $1,959.86. This competitively awarded, firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and will...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.04 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of VIMPAT 10 mg/ml Solution in 200ml quantities. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. VIMPAT (lacosamide) is a prescription anticonvulsant medication used in the treatment of...
- The Defense Logistics Agency awarded a $1,020.96 delivery order to AmerisourceBergen Drug Corp for 60 tablets of VIMPAT 100 mg on August 7, 2025, with a completion date of August 8, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. VIMPAT (lacosamide) is a prescription medication used in the treatment of partial-onset seizures and is being supplied to support federal medical procurement needs. The vendor, headquartered in Conshohocken,...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for VIMPAT 10 mg/ml solution in 200 ml quantities, with a ceiling value of $1,048.32. This is a firm fixed-price delivery order with an ultimate completion date of September 4, 2025, awarded on September 3, 2025. The award carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...